Skip to content

Author

K. Lanctôt

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications

Abstract The field of Alzheimer's disease (AD) research has seen major advances in understanding manifestations of AD‐related neuropsychiatric symptoms (NPS), including recent addition of NPS to the 2024 National Institute of Aging–Alzheimer's Association (NIA‐AA) clinical staging framework. This focused review highlig...

K. Sankhe, Daniella Vellone, Dylan X. Guan et al. · 0 citations
Open access Oct 2026

White matter hyperintensities moderate neuropsychiatric response to N-acetylcysteine and exercise therapy in vascular mild cognitive impairment

Findings support the importance of optimizing care for cerebrovascular risk factors in this vulnerable population and support the importance of optimizing care for cerebrovascular risk factors in this vulnerable population.

Ethan Mah, D. Gallagher, Ye-Jin Kang et al. · 0 citations
Open access Aug 2026

The effect of theta-gamma coupling on response to cognitive remediation combined with transcranial direct current stimulation in older adults at high risk for dementia: a PACt-MD secondary analysis.

The PACt-MD study demonstrated that combined cognitive remediation (CR) and transcranial direct current stimulation (tDCS) slows global cognitive decline in individuals with mild cognitive impairment (MCI) or remitted major depressive disorder (rMDD) over a median follow-up of four years. Prefrontal theta-gamma couplin...

Heather J. Brooks, Mina Mirjalili, Clement Ma et al. · 0 citations
Review Open access Aug 2026

Beyond control in psychiatric research: systematic review and meta-analysis of placebo treatment responses across major psychiatric conditions in citalopram and escitalopram RCTs.

BACKGROUND Placebos have historically been used as comparative tools in randomised controlled trials (RCTs), but their therapeutic effect, particularly in psychiatric conditions, warrant a more detailed exploration to improve research design and clinical practice. AIMS This systematic review and meta-analysis examine...

M. Ahmadzad-Asl, Roxana Jabbarinejad, D. Shekouh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.